E-Folder
#1 in Business Subscribe Email Print

You are here: Home > Business > Strategic Planning > Combining BPM And Strategic Technology Planning

Tags

  • strategic
  • involved
  • patients
  • companies involved
  • technology planning
  • right technology

  • Links

  • Frustrated: Is Working Melaleuca from Home worth it?
  • Paper Clip Management
  • Latent Semantic Indexing This Is New
  • E-Folder - Combining BPM And Strategic Technology Planning

    Business Performance Management abbreviated BPM and commonly overlapped with enterprise resource planning or strategic planning has and ought to be directly l
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    inked with strategic technology planning.

    All levels of planning and strategy making and implementation decisions move in closed coordination with the overal
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    l business objective as followed by BPM. BPM covers various managerial aspects of the business and works itself towards the overall performance objective of t
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    he firm by catering to various departments. For the overall growth and achieve the bigger picture it is essential to view BPM in consonance with other importa
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    t aspects of which an extremely crucial one is strategic technology planning.

    The Importance of Technology Planning: Technology planning is important not on
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ly because it acts as a decider of the future course but also because it entails huge expenses. If the key directions are taken by keeping overall BPM in the
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    background, the planning promises to be much more effective and useful. For instance, supervision and reporting which is an important BPM tool can be facilita
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ed by the right technology planning and infusion. The use of right technology tools to facilitate business performance can be widely witnessed in any area. A
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    simple graphical representation of facts collated over the last financial year can speak tons for itself rather than spending colossal amount of time in goin
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    g through each report. This seemingly tedious task can be immensely simplified with the right technological planning.

    All that is required is a realization t
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    at technology induced processes can impart the requisite level of efficiency and speed to the overall operability. Performance in the present modern terms is
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    anyways defined as the capacity to deliver the best at the fastest pace, which can be imparted only by the apt technology, oriented tools that must be careful
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ly opted for.

    The key principle to keep here in mind is that complex does not mean efficient. Do not be overwhelmed by the varied offerings as advertised by
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    the technical offering firms. The resources that might sound interesting could prove to be completely futile if do not suit your firm’s working patterns and o
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    erall performance management criterions.

    The decision must be diligently made depending upon the exact definition of requirements and a performance gap analy
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    sis as undertaken by BPM. This precise gap analysis can clearly outline the present state and corresponding future requirements thus outlining the features re
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    quired in your technology tools and equipments.

    Few benefits that must be looked out for while planning your technology portfolio include:


    • Automatic n
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    tifications
    • The requisite integration of resources
    • Filling up of gaps
    • Viability analysis
    • Adaptation facilitation
    • Expansio
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    n opportunities
    • Coordination among various departments and expansion plans
    • Networking

    Well in fact, the list is endless and the exact benefit l
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ist can be drawn based upon your requirements and how you plan to combine the strategic technology aspects with your business performance plans and objectives


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-folder.org.ua/article/44596/e-folder-Combining-BPM-And-Strategic-Technology-Planning.html">Combining BPM And Strategic Technology Planning</a>

    BB link (for phorums):
    [url=http://www.e-folder.org.ua/article/44596/e-folder-Combining-BPM-And-Strategic-Technology-Planning.html]Combining BPM And Strategic Technology Planning[/url]

    Related Articles:

    Compliance Jobs Interview Tips - Insurance Recruitment Advice

    Network - Use the Grapevine

    Managers: Don't Write Off Public Relations!

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com